hearing/vestibular/ear
N |
• normal gait and swimming ability indicating absence of vestibular abnormalities
|
• after 5 months of age
|
• progressive OHC loss beginning around 3 months of age and moves from the cochlear base to the apex
• loss is evident in the midcochlear turns at P100
• treatment with an apoptosis inhibitor reduces OHC loss
|
• expression analysis indicates enhanced apoptosis in OHC
|
• first detectable with high frequencies at P40
• treatment with an apoptosis inhibitor lowers ABR thresholds
|
• lower amplitudes at 7 weeks of age compared to mice homozygous for Cdh23ahl
• treatment with an apoptosis inhibitor increases amplitudes
|
• at 22 weeks of age, at all frequencies tested
|
• develops by P27
|
nervous system
• after 5 months of age
|
• progressive OHC loss beginning around 3 months of age and moves from the cochlear base to the apex
• loss is evident in the midcochlear turns at P100
• treatment with an apoptosis inhibitor reduces OHC loss
|
• expression analysis indicates enhanced apoptosis in OHC
|
behavior/neurological
N |
• normal gait and swimming ability indicating absence of vestibular abnormalities
|
• at 20 weeks of age in response to a 20 kHz 90 dB sound pressure level tone burst
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
autosomal recessive nonsyndromic deafness 12 | DOID:0110467 |
OMIM:601386 |
J:174758 |